Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
Clinical Cancer Research,  Clinical Article

Jamieson NB et al. – The authors found that that there was incomplete adherence to the REMARK guidelines with inadequate methodology reporting as well as failure to perform multivariate analysis. Addressing the persistent incomplete adoption of these criteria may eventually result in the incorporation of molecular marker assessment within PDAC management algorithms.


  • Systematic review and meta-analysis of the published literature for immunohistochemistry-based biomarkers of PDAC outcome
  • Dual search strategy applied to PubMed database through January 6th 2010, to identify cohort studies that reported associations between immunohistochemical biomarker expression and survival outcomes in PDAC, and conformed to REMARK criteria

  • 103 distinct proteins, which met all inclusion criteria
  • Promising markers that emerged for prediction of OS included, BAX (HR 0.31, CI: 0.71-0.56), Bcl-2 (HR: 0.41, CI: 0.27-0.63), Survivin (HR: 0.46, CI: 0.29-0.73), Ki-67: (HR 2.42, CI: 1.87-3.14), COX-2 (HR: 1.39, CI: 1.13-1.71), E-cadherin (HR: 1.80, CI: 1.33-2.42) and S100 calcium binding proteins in particular S100A2 (HR: 3.23, CI: 1.58-6.62)

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx


Most Popular Oncology Articles

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Make smarter career moves with less time.

Sign up for our free job placement service today and have a dedicated career consultant help locate the right physician job for you!
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List